参考文献/References:
1 James JJ.The current status of digital mammography[J]. Clin Radiol,2004, 59(1):1-10.
2 Tozaki M,Yamashita A, Kawakami M, et al. Diagnosis of breast cancer extent using dynamic multidetector-row CT:correlation between MPR imaging and pathological cross-sections. Nippon Igaku Hoshasen Gakkai zasshi[J]. Nippon Acta Radiol, 2000, 60(11):560-567.
3 Chen SC,Cheung YC, Su CH, et al. Analysis of sonographic features for the differentiation of benign and malignant breast tumors of differentsizes[J]. Ultrasound Obstetrics Gynecol, 2004, 23(2):188-193.
4 Milz P, Lienemann A, Kessler M, et al. Evaluation of breast lesions by power Doppler sonography[J]. Eur Radiol, 2001, 11(4):547-554.
5 Algul A, Balci P, Secil M, et al. Contrast enhanced power Doppler and color Doppler ultrasound in breast masses:Efficiency in diagnosis and contributions to differential diagnosis[J]. Tani Girisim Radiol,2003, 9(2):199-206.
6 Mesaki K, Hisa N, Kubota K, et al. Differentiation of benign and malignant breast tumors using doppler spectral parameters including acceleration time index[J]. Oncol Report, 2003, 10(4):945-950.
7 Stuhrmann M, Aronius R, Schietzel M. Tumor vascularity of breast lesions:potentials and limits of contrast-enhanced Doppler sonography[J]. AJR, 2000, 175:1585-1589.
8 Kook SH, Kwag HJ. Value of contrast-enhanced power Doppler sonography using a microbubble echo-enhancing agent in evaluation of small breast lesions[J]. Clin Ultrasound, 2003, 31(5):227-238.
9 Baz E, Madjarh H, Reuss C, et al. The role of enhanced Doppler ultrasound in differentiation of beign vs.malignant scar leision after breast surgery for malignancy[J]. Ultrasound Obstet Gynecol, 2000,15(2):377-382.
10 Bone BK, Szabo B, Palko A, et al. Magnetic resonance imaging in the diagnosis of breast diseases[J]. Orvosi Hetilap, 2001, 142(39):2123-2131.
11 Cecil KM, Schnall MD, Siegelman ES, et al. The evaluation of human breast leisions with magnetic resonance imaging and proton magnetic resonance spectroscopy[J]. Breast Cancer Res Treatment,2001, 68(1):45-54.
12 Kuhl CK, Schild HH. Dynamic image interpretation of MRI of the breast[J]. Magn Reson Imaging, 2000, 12(6):965-974.
13 Yildiz A, Colak T, Gungor F, et al. Diagnostic value of 99mTc-MIBI scintimammography in patients with breast leisions[J]. Rev Espanola Med Nucl, 2001, 20(4):276-281.
14 Wahl RL. Current status of PET in breast cancer imaging, staging,and therapy[J]. Semin Roentgenol, 2001, 36(3):250-260.
15 Lenneux M, Borbath I, Berliere M, et al. The place of whole-body PET FDG for the diagnosis of distant recurrence of breast cancer[J]. Clin Positron Imaging, 2000, 3(2):45-49.
16 Hou MF, Chuang HY, Yang FO, et al. Comparison of mammography,sonography and physical examination for screening women at high risk of breast cancer in Taiwan[J]. Ultrasound Med Biol, 2002, 28(4):415-420.
17 Stavros AT, Thickman D, Rapp CL, et al. Solid breast nodules:use of sonography to distinguish between benign and malignant lesions[J]. Radiology, 1995, 196(1):123-134.
18 Liberman L, Morris EA, Lee MJY, et al. Breast lesions detected on MR imaging:features andpositive predictive value[J]. Am J Roentgenol,2002, 179(1):171-178.
19 Kamphausen BH, Toellner T, Ruschenburg I. The value of ultrasound-guided fine-needle aspiration cytology of the breast:354cases with cytohistological correlation[J]. Anticancer Res, 2003, 23(3C):3009-3013.
20 Yeow KM, Lo YF, Wang CS, et al. Ultrasound-guided core needle biopsy as an initial diagnostic test for palpable breast masses[J]. Vascular Int Radiol, 2001, 12(11):1313-1317.
相似文献/References:
[1]杨雷,袁卫红,王家平,等.99Tcm-MIBI显像与钼靶X线对乳腺癌诊断的比较研究[J].国际放射医学核医学杂志,2016,40(2):111.[doi:10.3760/cma.j.issn.1673-4114.2016.02.005]
Yang Lei,Yuan Weihong,Wang Jiaping,et al.Diagnostic value of technetium 99Tcm sestamibi and X-ray mammography in breast cancer: a comparison study[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):111.[doi:10.3760/cma.j.issn.1673-4114.2016.02.005]
[2]马乐,张万春,李晓敏.乳腺癌前哨淋巴结核素显像新进展[J].国际放射医学核医学杂志,2016,40(2):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
Ma Le,Zhang Wanchun,Li Xiaomin.Evolution of radionuclide imaging of sentinel node lymphscintigraphy in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
[3]储小飞,赵舒怡,樊赛军.肿瘤干细胞与辐射抗性的研究进展[J].国际放射医学核医学杂志,2015,39(5):431.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 019]
chu xiaofei,zhao shuyi,fan saijun..advance progress of cancer stem cells and radioresistance[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):431.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 019]
[4]陈伟君,孙达.99Tcm-MIBI显像在乳腺癌新辅助化疗中的应用价值[J].国际放射医学核医学杂志,2015,39(6):487.[doi:10.3760/cma.j.issn.1673-4114.2015.06.011]
Chen Weijun,Sun Da.Clinical value of 99Tcm-MIBI imaging in neoadjuvant chemotherapy of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):487.[doi:10.3760/cma.j.issn.1673-4114.2015.06.011]
[5]胡鸿,唐刚华,聂大红.乳腺癌分子显像研究进展[J].国际放射医学核医学杂志,2015,39(1):91.[doi:10.3760/cma.j.issn.1673-4114.2015.01.019]
Hu Hong,Tang Ganghua,Nie Dahong.Progress on molecular imaging of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):91.[doi:10.3760/cma.j.issn.1673-4114.2015.01.019]
[6]黄娟,颜剑豪,梁联保,等.注射钆剂后弥散加权成像对乳腺肿瘤诊断的影响[J].国际放射医学核医学杂志,2015,39(4):287.[doi:10.3760/cma.j.issn.1673-4114.2015.04.003]
Huang Juan,Yan Jianhao,Liang Lianbao,et al.Evaluation of the diffusion-weighted imaging after contrast for the characterization of breast tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):287.[doi:10.3760/cma.j.issn.1673-4114.2015.04.003]
[7]李雯,冯彦林.18F-FDG PET/CT评估三阴性乳腺癌新辅助化疗疗效的研究进展[J].国际放射医学核医学杂志,2014,38(3):197.[doi:10.3760/cma.j.issn.1673-4114.2014.03.013]
Li Wen,Feng Yanlin.Advances of assessment with 18F-FDG PET/CT in triple-negative breast cancer during neoadjuvant chemotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):197.[doi:10.3760/cma.j.issn.1673-4114.2014.03.013]
[8]殷丽娜,张旭霞,张俊香,等.Wnt/β-catenin信号通路——乳腺癌的潜在治疗靶点[J].国际放射医学核医学杂志,2014,38(4):252.[doi:10.3760/cma.j.issn.1673-4114.2014.04.011]
Yin Lina,Zhang Xuxia,Zhang Junxiang,et al.The Wnt/β-catenin signaling pathway-a potential therapeutic target of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):252.[doi:10.3760/cma.j.issn.1673-4114.2014.04.011]
[9]刘超,邓智勇,刘鹏杰,等.89SrCL2与唑来膦酸联合治疗乳腺癌转移性骨肿瘤的疗效分析[J].国际放射医学核医学杂志,2014,38(5):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
Liu Chao,Deng Zhi-yong,Liu Peng-jie,et al.Analysis on the curative effect of combination therapy with zoledronic acid and 89SrCL2 on bone tumor with breast cancer metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
[10]胡梦裳,章斌.PET/CT显像在乳腺癌疗效评价及预后中的作用[J].国际放射医学核医学杂志,2014,38(5):332.[doi:10.3760/cma.j.issn.1673-4114.2014.05.013]
Hu Meng-shang,Zhang Bin.The role of PET/CT imaging in the evaluation of the efficacy and prognosis of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):332.[doi:10.3760/cma.j.issn.1673-4114.2014.05.013]